Orchid Pharma Limited

NSE ORCHPHARMA.NS

Orchid Pharma Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 8.40%

Orchid Pharma Limited Return on Capital Employed (ROCE) is 8.40% for the year ending March 31, 2024, a -18.69% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Orchid Pharma Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 10.33%, a 483.28% change year over year.
Orchid Pharma Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was -2.70%, a 31.42% change year over year.
Orchid Pharma Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was -3.93%, a 4.58% change year over year.
Orchid Pharma Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was -4.12%, a -139.71% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NSE: ORCHPHARMA.NS

Orchid Pharma Limited

CEO	Mr. Rajnish Rohatgi B. Tech.
IPO Date	July 1, 2002
Location	India
Headquarters	Orchid Towers
Employees	871
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

Key trends

Past 5 years